189 related articles for article (PubMed ID: 15981676)
1. Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.
Matsui H; Udaka F; Oda M; Tamura A; Kubori T; Nishinaka K; Kameyama M
Ann Nucl Med; 2005 May; 19(3):225-9. PubMed ID: 15981676
[TBL] [Abstract][Full Text] [Related]
2. Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy.
Matsui H; Udaka F; Oda M; Kubori T; Nishinaka K; Kameyama M
Auton Neurosci; 2005 Apr; 119(1):56-60. PubMed ID: 15893708
[TBL] [Abstract][Full Text] [Related]
3. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake.
Reinhardt MJ; Jüngling FD; Krause TM; Braune S
Eur J Nucl Med; 2000 May; 27(5):595-600. PubMed ID: 10853817
[TBL] [Abstract][Full Text] [Related]
4.
Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
[TBL] [Abstract][Full Text] [Related]
5. Thyroid MIBG uptake in Parkinson's disease with diabetes mellitus.
Jang W; Kim JS; Cho JW; Ahn JY; Choi YY; Kim HT
Clin Auton Res; 2013 Aug; 23(4):221-4. PubMed ID: 23843160
[TBL] [Abstract][Full Text] [Related]
6. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
[TBL] [Abstract][Full Text] [Related]
7. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
[TBL] [Abstract][Full Text] [Related]
8. Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
Brumberg J; Kuzkina A; Lapa C; Mammadova S; Buck A; Volkmann J; Sommer C; Isaias IU; Doppler K
Neurobiol Dis; 2021 Jun; 153():105332. PubMed ID: 33722614
[TBL] [Abstract][Full Text] [Related]
9. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
[TBL] [Abstract][Full Text] [Related]
10. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy.
Lee PH; Yeo SH; Kim HJ; Youm HY
Mov Disord; 2006 Nov; 21(11):1975-7. PubMed ID: 16960860
[TBL] [Abstract][Full Text] [Related]
11. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
[TBL] [Abstract][Full Text] [Related]
13. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
Parkinsonism Relat Disord; 2006 Jun; 12(5):284-8. PubMed ID: 16549383
[TBL] [Abstract][Full Text] [Related]
14. [123I-metaiodobenzylguanidine myocardial scintigraphy in the differential diagnosis of patients with parkinsonian syndromes -- case reports].
Leńska-Mieciek M; Derecka-Charzyńska I; Fiszer U; Królicki L; Kułakowski P
Neurol Neurochir Pol; 2005; 39(5):424-8. PubMed ID: 16273470
[TBL] [Abstract][Full Text] [Related]
15. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
[TBL] [Abstract][Full Text] [Related]
16. Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging.
Marini C; Bandettini di Poggio M; Pomposelli E; Marchese R; Nobili F; Morbelli SD; Villa G; Abbruzzese G; Sambuceti G
Clin Nucl Med; 2010 May; 35(5):311-6. PubMed ID: 20395701
[TBL] [Abstract][Full Text] [Related]
17. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease.
Yoshita M; Hayashi M; Hirai S
Nucl Med Commun; 1998 Feb; 19(2):137-42. PubMed ID: 9548197
[TBL] [Abstract][Full Text] [Related]
18. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
Ohmura M
J Nucl Med; 2000 Sep; 41(9):1594-5. PubMed ID: 10994743
[No Abstract] [Full Text] [Related]
19. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
20. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
